AYTU Aytu BioPharma, Inc.
$1.97▲ +3.68%
Healthcare
Other
Volume 20.2K
Avg Volume (10D) 21.7K
Key Metrics & Fundamentals
Market Cap
$21.41M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.80 - 3.07
% vs 50 MA
-6.99%
% vs 200 MA
-15.25%
RSI-14
45.0
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.73
Free Cash Flow
$4.39M
Gross Rev
$16.11M
Gross Profit
$10.41M
EBITDA
$517,000
COGS
$5.70M
Operating Exp
$11.19M
Operating Income
-$777,000
EBIT
-$777,000
Pretax Income
-$4,000
Net Income
-$15,000
EPS (Diluted)
0.00
Price & Volume History
Loading chart…
Recent News
Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?
Zacks · Oct 7, 2026 11:08 AM ET
Aytu BioPharma, Inc. Q4 2026 Earnings Call Summary
Moby · Sep 23, 2026 8:30 AM ET
Aytu BioPharma Inc (AYTU) (Q4 2026) Earnings Call Highlights: EXXUA Launch Accelerates as ...
GuruFocus.com · Sep 23, 2026 1:00 AM ET
Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates
Zacks · Sep 22, 2026 5:15 PM ET
Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
ACCESS Newswire · Sep 22, 2026 4:05 PM ET
Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 2026
ACCESS Newswire · Sep 16, 2026 4:30 PM ET
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
Zacks · Sep 14, 2026 5:35 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AYTU's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.